The competition in the lucrative obesity treatment market has intensified with Viking Therapeutics announcing a critical operational milestone. The biopharma ...

The Viking Age, spanning roughly from the late 8th to the early 11th century in Scandinavia, saw women play crucial roles in ...

Finally, the Green Bay Packers managed to win comfortably in a game that they were expected to do so. Playing without Josh ...

Ideas about Vikings and Norse mythology come mostly from much later medieval sources, leaving plenty of room for ...

In the second scrimmage of the season, the Palo Alto High School Vikings (0-0) fell to the Junipero Serra Padres (0-0), 58-42 ...

For those with decades left in their investing journey, these top healthcare stocks could be worthy portfolio contenders.

Assassin's Creed Valhalla producer Julian Laferriere answered a ton of questions, including why longship combat got cut, in a ...

Architects begin applying the lens of domestic science to the kitchen, with many inspired by the work of the famed Viennese ...

Concurrently, Viking is conducting the Phase 3 VANQUISH-2 study of subcutaneous VK2735 in patients with type 2 diabetes who have obesity or are overweight. That trial is currently enrolling patients, ...

Viking beat Wall Street's third quarter profit expectation by a penny per share, at $1.20 adjusted EPS, while also delivering ...

View Viking Acquisition Corp. I Class A VACI stock quote prices, financial information, real-time forecasts, and company news from CNN.

Lilly's tirzepatide is sold as Mounjaro for Type 2 diabetes and as Zepbound for weight loss -- but doctors have prescribed ...